BioCorRx, Inc. Announces New Agreements With Wellness Centers in Slidell, LA, Memphis and Nashville, TN, and Philadelphia, PA
Jan 14, 2016
OTC Disclosure News Service
– BioCorRx, Inc. Announces New Agreements With Wellness Centers in Slidell, LA, Memphis and Nashville, TN, and Philadelphia, PA
LOS ANGELES, CA–(Marketwired – Jan 14, 2016) – BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx® Recovery Program, a non-addictive Medication-Assisted Treatment (MAT) program used in the treatment of alcohol and opioid addiction, announces new distribution agreements with existing wellness centers. The agreements are part of the company’s continued focus to distribute its addiction treatment program, built around long-lasting Naltrexone therapy, to independent locations nationally. The new centers are to be located in Slidell, LA, Memphis, TN, Nashville, TN, and Philadelphia, PA. Visit www.BeatAddiction.com for the most up to date list of locations treating patients currently or for those coming soon.
“Since our appearance on Fox Friends about two months ago, we have experienced an increase in medical practices wanting to use our program to treat patients, especially in the South and on the East Coast. We are excited to develop those parts of the country so that families out there can have more convenient access to our effective program,” says Brady Granier, COO interim CEO.
Visit BioCorRx, Inc.’s company website at www.BioCorRx.com to receive the most up to date company information. For families interested in learning more about the treatment program, visit www.BeatAddiction.com.
BioCorRx, Inc. ® (OTCQB: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive Medication-Assisted Treatment (MAT) program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the non-addictive medicine, Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Tactical Growth Partners LLC
1-800-625-2236 ext. 7770
Copyright © 2016 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.